Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

The ecarin clotting time, a universal method to quantify direct thrombin inhibitors.

Nowak G.

Pathophysiol Haemost Thromb. 2003 Jul-2004 Aug;33(4):173-83. Review.

PMID:
15583446
2.

Modified plasma-based ecarin clotting time assay for monitoring of recombinant hirudin during cardiac surgery.

Choi TS, Khan AI, Greilich PE, Kroll MH.

Am J Clin Pathol. 2006 Feb;125(2):290-5.

PMID:
16393689
3.

Monitoring of recombinant hirudin: assessment of a plasma-based ecarin clotting time assay.

Pötzsch B, Hund S, Madlener K, Unkrig C, Müller-Berghaus G.

Thromb Res. 1997 Jun 1;86(5):373-83.

PMID:
9211628
4.

Ecarin clotting time but not aPTT correlates with PEG-hirudin plasma activity.

Moser M, Ruef J, Peter K, Kohler B, Gulba DC, Paterna N, Nordt T, Kübler W, Bode C.

J Thromb Thrombolysis. 2001 Oct;12(2):165-9.

PMID:
11729368
5.

Clinical monitoring of hirudin and direct thrombin inhibitors.

Nowak G.

Semin Thromb Hemost. 2001 Oct;27(5):537-41. Review.

PMID:
11668425
6.

Ecarin clotting time is sensitive to heparinoids: comparison of two different techniques.

Demir M, Iqbal O, Untch B, Hoppensteadt DA, Gaikwad BS, Fareed J.

Clin Appl Thromb Hemost. 2001 Jan;7(1):38-43.

PMID:
11190903
7.

Comparison of three methods for measuring PEG-hirudin in blood.

Hoffmann JJ, Janssen WC.

Blood Coagul Fibrinolysis. 2001 Oct;12(7):577-81.

PMID:
11685047
8.

Hirudin determination in plasma can be strongly influenced by the prothrombin level.

Lindhoff-Last E, Piechottka GP, Rabe F, Bauersachs R.

Thromb Res. 2000 Oct 1;100(1):55-60.

PMID:
11053617
9.

Point-of-care ecarin clotting time versus activated clotting time in correlation with bivalirudin concentration.

Casserly IP, Kereiakes DJ, Gray WA, Gibson PH, Lauer MA, Reginelli JP, Moliterno DJ.

Thromb Res. 2004;113(2):115-21.

PMID:
15115666
10.

Quantitative determination of hirudin in blood and body fluids.

Nowak G, Bucha E.

Semin Thromb Hemost. 1996;22(2):197-202.

PMID:
8807717
11.

[Follow-up of the treatment by direct thrombin inhibitors: activated partial thromboplastin time or ecarin clotting time].

Kher A, Gouin I, Samama MM.

Ann Biol Clin (Paris). 2000 Sep-Oct;58(5):575-9. Review. French.

12.

Methods for the monitoring of direct thrombin inhibitors.

Hafner G, Roser M, Nauck M.

Semin Thromb Hemost. 2002 Oct;28(5):425-30. Review.

PMID:
12420237
13.

A functional clotting assay to monitor the hirudin dosage.

Zakir RM, Hoffman W, Bhatt BA, Spillert CR.

Blood Coagul Fibrinolysis. 2007 Mar;18(2):119-23.

PMID:
17287627
14.

Ecarin chromogenic assay--a new method for quantitative determination of direct thrombin inhibitors like hirudin.

Lange U, Nowak G, Bucha E.

Pathophysiol Haemost Thromb. 2003 Jul-2004 Aug;33(4):184-91.

PMID:
15583447
15.

[Ecarin chromogenic assay: an innovative test for quantitative determination of direct thrombin inhibitors in plasma].

Lange U, Olschewski A, Nowak G, Bucha E.

Hamostaseologie. 2005 Aug;25(3):293-300. German.

PMID:
16113754
16.

Monitoring of r-hirudin anticoagulation during cardiopulmonary bypass--assessment of the whole blood ecarin clotting time.

Pötzsch B, Madlener K, Seelig C, Riess CF, Greinacher A, Müller-Berghaus G.

Thromb Haemost. 1997 May;77(5):920-5.

PMID:
9184403
17.

Monitoring of anticoagulant effects of direct thrombin inhibitors.

Fenyvesi T, Jörg I, Harenberg J.

Semin Thromb Hemost. 2002 Aug;28(4):361-8.

PMID:
12244483
18.
19.

Comparative anticoagulant effects of various thrombin inhibitors, as determined in the ecarin clotting time method.

Callas DD, Fareed J.

Thromb Res. 1996 Sep 15;83(6):463-8. No abstract available.

PMID:
8885140
20.

Activated partial thromboplastin time is more sensitive than ecarin clotting time for monitoring low doses of desirudin.

Mazoyer E, Drouet L, Delahousse B, Gruel Y, Rouyrre N.

Thromb Res. 2002 May 15;106(4-5):271-2. No abstract available.

PMID:
12297138

Supplemental Content

Support Center